Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study

Kristine A. Frerichs; Monique C. Minnema; Mark-David Levin; Annemiek Broyl; Gerard Bos; Marie Jose Kersten; Tuna Mutis; Christie P. M. Verkleij; Patricia W. C. Bosman; Saskia K. Klein; Sonja Zweegman; Pieter Sonneveld; Niels W. C. J. Van de Donk

doi:https://doi.org/10.1182/blood-2019-123383

Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study

Kristine A. Frerichs, Monique C. Minnema, Mark-David Levin, Annemiek Broyl, Gerard Bos, Marie Jose Kersten, Tuna Mutis, Christie P. M. Verkleij, Patricia W. C. Bosman, Saskia K. Klein, Sonja Zweegman, Pieter Sonneveld, Niels W. C. J. Van de Donk

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Blood
Volume	134
DOIs	https://doi.org/10.1182/blood-2019-123383
Publication status	Published - 13 Nov 2019

Access to Document

https://doi.org/10.1182/blood-2019-123383

Cite this

Frerichs, K. A., Minnema, M. C., Levin, M.-D., Broyl, A., Bos, G., Kersten, M. J., Mutis, T., Verkleij, C. P. M., Bosman, P. W. C., Klein, S. K., Zweegman, S., Sonneveld, P., & Van de Donk, N. W. C. J. (2019). Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study. Blood, 134. https://doi.org/10.1182/blood-2019-123383

@article{1f7d678f15004d4f8bd793462260c7b8,

title = "Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study",

author = "Frerichs, {Kristine A.} and Minnema, {Monique C.} and Mark-David Levin and Annemiek Broyl and Gerard Bos and Kersten, {Marie Jose} and Tuna Mutis and Verkleij, {Christie P. M.} and Bosman, {Patricia W. C.} and Klein, {Saskia K.} and Sonja Zweegman and Pieter Sonneveld and {Van de Donk}, {Niels W. C. J.}",

year = "2019",

month = nov,

day = "13",

doi = "https://doi.org/10.1182/blood-2019-123383",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

}

Frerichs, KA, Minnema, MC, Levin, M-D, Broyl, A, Bos, G, Kersten, MJ , Mutis, T , Verkleij, CPM, Bosman, PWC, Klein, SK, Zweegman, S, Sonneveld, P & Van de Donk, NWCJ 2019, 'Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study', Blood, vol. 134. https://doi.org/10.1182/blood-2019-123383

TY - JOUR

T1 - Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study

AU - Frerichs, Kristine A.

AU - Minnema, Monique C.

AU - Levin, Mark-David

AU - Broyl, Annemiek

AU - Bos, Gerard

AU - Kersten, Marie Jose

AU - Mutis, Tuna

AU - Verkleij, Christie P. M.

AU - Bosman, Patricia W. C.

AU - Klein, Saskia K.

AU - Zweegman, Sonja

AU - Sonneveld, Pieter

AU - Van de Donk, Niels W. C. J.

PY - 2019/11/13

Y1 - 2019/11/13

U2 - https://doi.org/10.1182/blood-2019-123383

DO - https://doi.org/10.1182/blood-2019-123383

M3 - Meeting Abstract

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

ER -